Literature DB >> 9129158

Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.

C D Partidos1, A Delmas, M W Steward.   

Abstract

We have studied the immunogenicity of a synthetic peptide representing a cytotoxic T cell epitope (CTL) from the nucleoprotein of measles virus (MV). For the induction of peptide and MV-specific CTL responses after subcutaneous immunization, covalent linkage of the CTL epitope to a T-helper epitope was required. The presence of two copies of the T-helper epitope at the amino terminus of the CTL epitope (TT-CTL) resulted in the induction of strong CTL responses after administration in saline. In contrast, a chimeric peptide with one copy of the T-helper epitope at the amino terminus of the CTL epitope (T-CTL) was weakly immunogenic when given in saline. Analysis of the structure of the TT-CTL chimeric peptide by CD spectroscopy revealed an alpha-helical conformation, as compared to the random coil conformation favored by the T-CTL chimeric peptide. In addition, the CD spectra of the TT-CTL peptide in the presence of small unilamellar vesicules (SUV) revealed an increased helicity, as compared to the spectra of the T-CTL chimera in the presence of SUV. This suggests that the amphipathic character of the TT-CTL chimeric construct favors its interaction with the cell membrane of antigen presenting cells, therefore, facilitating its cytosolic delivery for class I presentation. These findings highlight the importance of antigen structure for the in vivo induction of CTL responses and may have implications for the design of synthetic peptide vaccines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9129158     DOI: 10.1016/s0161-5890(96)00094-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  1 in total

1.  Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma.

Authors:  Victoria M Leb-Reichl; Melanie Kienzl; Anna Kaufmann; Angelika Stoecklinger; Birgit Tockner; Sophie Kitzmueller; Nadja Zaborsky; Markus Steiner; Gabriele Brachtl; Lisa Trattner; Patrick Kreideweiss; Christian Reinsch; Steffen Panzner; Richard Greil; Dirk Strunk; Johann W Bauer; Iris K Gratz; Christina Guttmann-Gruber; Josefina Piñón Hofbauer
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.